Highlights Evolva Holding SA

Equities

EVE

CH1262055788

Market Closed - Swiss Exchange Other stock markets 11:30:02 2024-06-28 EDT			5-day change	1st Jan Change
0.91 ^CHF	-0.22%		-6.19%	+26.39%

04-15	Evolva Shareholders Pass Resolutions to Revoke Liquidation, Delisting	MT
03-26	Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation	03-26	MT
Evolva Closes CHF20 Million Unit Sale to Lallemand's Danstar Ferment	12-28	MT
Danstar Ferment AG completed the acquisition of Evolva AG form Evolva Holding SA.	12-27	CI
Evolva Shareholders OK Unit Sale, Proposed Liquidation	12-22	MT
Evolva to Seek Shareholder Nod for Unit Sale, Proposed Liquidation	11-30	MT
Evolva Strikes CHF20 Million Deal to Sell Business to Lallemand's Danstar Ferment	11-21	MT
Danstar Ferment AG enters into an agreement to acquire Evolva AG form Evolva Holding SA for CHF 30 million.	11-20	CI
Evolva, Breko Sign Distribution Deal for Dietary Supplement Ingredient	11-14	MT
Evolva and Breko GmbH Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam	11-14	CI
Evolva Signs Distribution Deal with Chemical Group Lehvoss	23-09-28	MT
Evolva and LEHVOSS Sign Agreement for Distribution of Veri-teTM Resveratrol in over A Dozen European Countries	23-09-28	CI
Evolva, Nice & Green Agree to Term Amendments for CHF5 Million Facility	23-09-13	MT
Evolva Wins Thai Regulatory Nod for Nature-based Ingredient Veri-teTM Resveratrol	23-09-06	MT
Evolva Receives Approval for Veri-Te Resveratrol in Thailand	23-09-06	CI
Evolva Posts Larger H1 Loss; Revenue Slides Down	23-08-24	MT
Evolva Holding SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-22	CI
Evolva Gets Approval for Veri-te Resveratrol Use in Taiwan	23-07-25	MT
Evolva Receives FDA Approval for Veri-teTM Resveratrol in Taiwan	23-07-25	CI
SIX Group Makes Index Adjustments Following Review	23-07-11	MT
Evolva Withdraws FY23 Guidance Amid Strategic Financing Review	23-06-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Evolva Holding SA

Equities

EVE

CH1262055788

Highlights

Filters